Rodrigo Gajardo, PhD, is a seasoned professional with a Doctorate in Biotechnology, Virology, and Applied Microbiology from the University of Barcelona. With nearly 25 years of experience in the pharmaceutical and biotechnology industry, Dr. Gajardo has held various key positions. After serving as an Associate Professor of Microbiology and Virology at the University of Barcelona for five years, he transitioned into the pharmaceutical and biotech sector. Throughout his career, Dr. Gajardo has played instrumental roles in the development of complex pharmaceutical and biological medicinal products, from discovery to pharmacovigilance. His expertise spans regulatory strategy, viral safety, clinical trials, intellectual property, and documentation preparation. Dr. Gajardo has cultivated strong relationships with regulatory authorities worldwide, including the FDA, EMA, and TGA, and has extensive experience in ensuring compliance with GXPs, particularly GLP (Good Laboratory Practices) in preclinical studies.